Task Force Recommends Genetic Testing for Newly Diagnosed Colon Cancer Patients | GenomeWeb

NEW YORK (GenomeWeb) – A group of experts has recommended that newly diagnosed colorectal cancer patients should receive genetic tests to identify which ones may have Lynch syndrome, the American Gastroenterological Association said today.

The US Multi-Society Task Force on Colorectal Cancer, a group of specialists representing several professional organizations, recommends all new colorectal cancer patients should be tested for evidence of mismatch repair (MMR) deficiency.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.